Sugar Maple Asset Management’s GE HealthCare GEHC Stock Holding History

Sugar Maple Asset Management’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-55	Closed	-$4.3K	–	217
2024 Q4	$4.3K	Buy	+55	New	+$4.67K	﹤0.01%	235

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sugar Maple Asset Management's GEHC Position: Q1 2025 in Review

Sugar Maple Asset Management sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 55 shares — an estimated $4.3K sold.

Sugar Maple Asset Management first reported a position in GEHC in Q4 2024 and held it in 1 quarter. The position peaked at $4.3K in Q4 2024. 1,373 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

Sugar Maple Asset Management reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
Sugar Maple Asset Management sold 55 GE HealthCare shares in Q1 2025, an estimated $4.3K.
Sugar Maple Asset Management first reported a position in GE HealthCare in Q4 2024 and held it in 1 quarter.
Sugar Maple Asset Management's GE HealthCare position peaked at $4.3K in Q4 2024.
1,373 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Sugar Maple Asset Management's 13F filing for Q1 2025, filed 10 Apr 2025.